These new findings might lead to new treatment strategies; administration of anabolic agents such as teriparatide (a recombinant human parathyroid hormone) to enhance bone development, as is done in the treatment of osteoporosis and osteogenesis imperfecta might be considered [77, 78]. This evidence concerns the gene PTH and osteogenesis imperfecta.